Home > Boards > US Listed > Biotechs > Contrafect Corp (CFRX)

Anybody following in stock? Seems like a good

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Snakes531 Member Profile
 
Followed By 1
Posts 368
Boards Moderated 0
Alias Born 03/31/17
160x600 placeholder
ContraFect Announces Oral Presentations at the 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMI... GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
ContraFect to Present at 2020 ASM Biothreats GlobeNewswire Inc. - 1/22/2020 7:00:10 AM
ContraFect Partners with Leading Orthopedic Center in Europe to Provide Compassionate Use of Exebacase to Patients with Chron... GlobeNewswire Inc. - 1/13/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/10/2020 12:53:39 PM
ContraFect Announces First Patient Dosed in Pivotal Phase 3 DISRUPT Study of Exebacase as a Treatment for Staph aureus Bacter... GlobeNewswire Inc. - 1/10/2020 7:00:10 AM
ContraFect to Present at Biotech Showcase 2020 GlobeNewswire Inc. - 1/6/2020 5:30:10 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 1/6/2020 5:01:40 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 12/27/2019 5:29:53 PM
ContraFect Announces Initiation of Pivotal Phase 3 DISRUPT Study of Exebacase as a treatment for Staph aureus Bacteremia, Inc... GlobeNewswire Inc. - 12/20/2019 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 4:18:54 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/18/2019 4:04:03 PM
ContraFect Announces First Gram-negative Product Candidate CF-370, a Direct Lytic Agent Targeting Pseudomonas aeruginosa GlobeNewswire Inc. - 12/18/2019 7:00:10 AM
ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock GlobeNewswire Inc. - 12/17/2019 9:25:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/16/2019 4:36:58 PM
NexImmune Appoints Sol Barer as Chairman of the Board of Directors GlobeNewswire Inc. - 12/16/2019 7:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/16/2019 6:36:12 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/16/2019 6:32:13 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/16/2019 6:27:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/12/2019 5:04:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/11/2019 4:37:03 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 12/10/2019 4:44:42 PM
ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock and Concurrent $3 Million Private Pl... GlobeNewswire Inc. - 12/10/2019 8:46:39 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 12/9/2019 5:19:05 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/9/2019 5:16:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2019 5:08:26 PM
Snakes531   Monday, 01/14/19 11:18:20 AM
Re: None
Post # of 210 
Anybody following in stock? Seems like a good entry point but I don’t know why it dropped from $2 to .60

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist